Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Local Anesthesia Drugs Market by Drugs Type (Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine, Other local anesthetics), by Application (Injectable, Surface Anesthetic): Global Opportunity Analysis and Industry Forecast, 2021-2031

A31886

Pages: 260

Charts: 54

Tables: 84

Local Anesthesia Drugs Market Research, 2031

The global local anesthesia drugs market size was valued at $2.6 billion in 2021, and is projected to reach $4.7 billion by 2031, growing at a CAGR of 6.4% from 2022 to 2031. Local anesthesia drugs are widely used to numb specific parts of the body so that the doctor can stitch up a wound or can perform operation or biopsy without the patient feeling any pain.Local anesthesia drugs differ from general anesthesia because  general anesthesia drugs put the patient to sleep during the surgery or operation.

[COVIDIMPACTSTATEMENT]

However, with local anesthesia the patient will be conscious during the procedure. Also, local anesthesia drugs are used to provide relief from pain caused by cancer or joint diseases. These factors are anticipated to propel the local anesthesia drugs market size during the forecast period. 

The crucial role played by local anesthesia drugs in offering pain relief is anticipated to boost the market growth. The local anesthesia drugs relieve pain by blocking the nerves from carrying pain signal to the brain. This blockage saves the patients from feeling pain. Although this blockage is temporary and nerves will start working normally after some period of time. Local anesthesia is a simpler process as only the body is numbed while the patient is still awake. These factors are anticipated to boost the local anesthesia drugs market growth during the forecast period. 

Some of the side effects associated with local anesthesia drugs include vomiting and nausea. Also, the presence of general anesthesia as a substitute for local anesthesia is estimated to restrict the local anesthesia market demand in the coming years. General anesthesia is used for extensive and long procedures where after injecting anesthesia patients fall asleep and by the time the patient wakes up the surgery is done. 

Local anesthesia drugs offer several advantages to the patient as well as doctors. For instance, local anesthesia relieves pain while the patient is alert & conscious as only body is numb. Also, anesthesiologist is not required for injecting local anesthesia drugs. The surgeons or doctors can provide local anesthesia drugs before starting operation of procedure. The side-effects associated with local anesthesia drugs are very mild and uncommon. Owing to these factors, the risk of aspiration pneumonia is less, there is no delay in the procedure, and patients can go home sooner. Additionally, the cost of local anesthesia drugs namely procaine, chloroprocaine, and tetracaine is relatively less. These factors are anticipated to have positive impact on local anesthesia drugs industry during the projection timeframe. 

The key players profiled in this report include Novartis AG, Aspen Pharmacare, Sagent Pharmaceuticals, Pacira Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi, Mylan N.V., GSK plc., AstraZeneca plc, and Hikma Pharmaceuticals plc. 

The local anesthesia drugs market is segmented on the basis of drugs type, application, and region. As per drugs type, the market is divided into bupivacaine, ropivacaine, lidocaine, chloroprocaine, prilocaine, benzocaine, and other local anesthetics. By application, the market is classified into injectable and surface anesthetic. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

The local anesthesia drugs market is segmented into Drugs Type and Application.

[DRUGSTYPEGRAPH]

By drugs type, the Lidocaine segment dominated the market in 2021. Lidocaine is widely used local anesthesia drug that is used to produce numbness on skin before surgical injections or procedures. Lidocaine topical cream is used for inducing loss of feeling or numbness before specific medical procedures. Lidocaine is applied on skin or genital area to cause numbness or loss of feeling. It effectively works by blocking the transmission of nerve signals in the body that reduces the pain sensation. It is widely used to prevent pain caused by injections, minor surgeries, or drawing of blood from vein. These factors are anticipated to boost the Lidocaine segment growth during the forecast period. 

[APPLICATIONGRAPH]

By application, the injectable segment dominated the global local anesthesia drugs market share in 2021. The injectable local anesthesia drugs are quite common and they have been in use since long time. Also, the injectable anesthetics are cost effective that will be used for numbness during the medical procedures. The injectable local anesthesia drugs act as roadblock between source of pain and brain that temporarily inhibits the activity of nerves to transmit the signals to brain thereby creating a feeling of numbness in patients. These aspects are anticipated to boost the popularity of injectable local anesthesia drugs market in the analysis timeframe. 

[REGIONGRAPH]

By region, North America dominated the global market in 2021 and is anticipated to grow at a significant rate during the forecast period. This growth is majorly attributed to increase in the number of surgical procedures performed in this region. Also, improved access to healthcare facilities, rapid advancements in the healthcare sector, and high per capita income are the major growth driving factors. Additionally, rising cases of surgeries and chronic diseases are anticipated to boost the North America local anesthesia drugs market opportunity. For instance, the cases of skin or breast biopsy, surgical procedures involved in repairing broken bone, or stitching cuts is anticipated to propel the market demand in the coming years. 

Impact of COVID-19 on the Global Local Anesthesia Drugs Industry 

  • The COVID-19 pandemic has negatively impacted several businesses around the globe owing to social distancing norms and the closure of several businesses due to economic crisis 

  • However, the pandemic impact on the local anesthesia drugs market was moderate and the demand for local anesthesia drugs have shown moderate increase. This is majorly owing to increase in hospitalization rate owing to rise in the admission of patients to the hospitals for surgeries and health complications  

  • As the local anesthesia drugs are widely used in minor surgical procedures its demand during the pandemic has increased to some extent. However, only patients with severe health complications were admitted to the hospitals. Hospitals were committed to work closely with the healthcare providers and government during this crucial time to provide timely treatment to the patients who are in the need for same 

  • For instance, the cardiac care and bone & joint surgeries that involve several diagnostic tests and procedures have led to an increase in demand for local anesthesia drugs during the COVID-19 pandemic. Many hospitals have also stocked their inventory of essential medicines to avoid any delay in the treatment. At the same time, several non-emergency surgical procedures were delayed as hospitals were overwhelmed with COVID-19 patients 

  • The growing need to address the increasing demand for essential healthcare services, to enhance the capacity of healthcare systems, and to eliminate the backlog of care have led to moderate impact on the local anesthesia drugs market growth. Owing to all the above-mentioned factors, the local anesthesia drugs market demand moderately increased during the pandemic 

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the local anesthesia drugs market analysis from 2021 to 2031 to identify the prevailing local anesthesia drugs market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the local anesthesia drugs market segmentation assists to determine the prevailing local anesthesia drugs market forecast.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global local anesthesia drugs market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

  • By Drugs Type
    • Bupivacaine
    • Ropivacaine
    • Lidocaine
    • Chloroprocaine
    • Prilocaine
    • Benzocaine
    • Other local anesthetics
  • By Application
    • Injectable
    • Surface Anesthetic
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • United Arab Emirates
      • Saudi Arabia
      • South Africa
      • Rest of LAMEA


Key Market Players

  • Sagent Pharmaceuticals
  • Pfizer Inc.
  • Mylan N.V.
  • Fresenius Kabi AG
  • Pacira Pharmaceuticals, Inc.
  • Aspen Holdings
  • Septodont Healthcare India Pvt. Ltd.
  • Novartis AG
  • Baxter International Inc.
  • Teva Pharmaceutical Industries Ltd.
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report description

    • 1.2. Key market segments

    • 1.3. Key benefits to the stakeholders

    • 1.4. Research Methodology

      • 1.4.1. Primary research

      • 1.4.2. Secondary research

      • 1.4.3. Analyst tools and models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET OVERVIEW

    • 3.1. Market definition and scope

    • 3.2. Key findings

      • 3.2.1. Top impacting factors

      • 3.2.2. Top investment pockets

    • 3.3. Porter’s five forces analysis

    • 3.4. Market dynamics

      • 3.4.1. Drivers

      • 3.4.2. Restraints

      • 3.4.3. Opportunities

    • 3.5. COVID-19 Impact Analysis on the market

    • 3.6. Key Regulation Analysis

    • 3.7. Market Share Analysis

    • 3.8. Patent Landscape

    • 3.9. Regulatory Guidelines

    • 3.10. Value Chain Analysis

  • CHAPTER 4: LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE

    • 4.1. Overview

      • 4.1.1. Market size and forecast

    • 4.2. Bupivacaine

      • 4.2.1. Key market trends, growth factors and opportunities

      • 4.2.2. Market size and forecast, by region

      • 4.2.3. Market share analysis by country

    • 4.3. Ropivacaine

      • 4.3.1. Key market trends, growth factors and opportunities

      • 4.3.2. Market size and forecast, by region

      • 4.3.3. Market share analysis by country

    • 4.4. Lidocaine

      • 4.4.1. Key market trends, growth factors and opportunities

      • 4.4.2. Market size and forecast, by region

      • 4.4.3. Market share analysis by country

    • 4.5. Chloroprocaine

      • 4.5.1. Key market trends, growth factors and opportunities

      • 4.5.2. Market size and forecast, by region

      • 4.5.3. Market share analysis by country

    • 4.6. Prilocaine

      • 4.6.1. Key market trends, growth factors and opportunities

      • 4.6.2. Market size and forecast, by region

      • 4.6.3. Market share analysis by country

    • 4.7. Benzocaine

      • 4.7.1. Key market trends, growth factors and opportunities

      • 4.7.2. Market size and forecast, by region

      • 4.7.3. Market share analysis by country

    • 4.8. Other local anesthetics

      • 4.8.1. Key market trends, growth factors and opportunities

      • 4.8.2. Market size and forecast, by region

      • 4.8.3. Market share analysis by country

  • CHAPTER 5: LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION

    • 5.1. Overview

      • 5.1.1. Market size and forecast

    • 5.2. Injectable

      • 5.2.1. Key market trends, growth factors and opportunities

      • 5.2.2. Market size and forecast, by region

      • 5.2.3. Market share analysis by country

    • 5.3. Surface Anesthetic

      • 5.3.1. Key market trends, growth factors and opportunities

      • 5.3.2. Market size and forecast, by region

      • 5.3.3. Market share analysis by country

  • CHAPTER 6: LOCAL ANESTHESIA DRUGS MARKET, BY REGION

    • 6.1. Overview

      • 6.1.1. Market size and forecast By Region

    • 6.2. North America

      • 6.2.1. Key trends and opportunities

      • 6.2.2. Market size and forecast, by Drugs Type

      • 6.2.3. Market size and forecast, by Application

      • 6.2.4. Market size and forecast, by country

        • 6.2.4.1. U.S.
          • 6.2.4.1.1. Key market trends, growth factors and opportunities
          • 6.2.4.1.2. Market size and forecast, by Drugs Type
          • 6.2.4.1.3. Market size and forecast, by Application
        • 6.2.4.2. Canada
          • 6.2.4.2.1. Key market trends, growth factors and opportunities
          • 6.2.4.2.2. Market size and forecast, by Drugs Type
          • 6.2.4.2.3. Market size and forecast, by Application
        • 6.2.4.3. Mexico
          • 6.2.4.3.1. Key market trends, growth factors and opportunities
          • 6.2.4.3.2. Market size and forecast, by Drugs Type
          • 6.2.4.3.3. Market size and forecast, by Application
    • 6.3. Europe

      • 6.3.1. Key trends and opportunities

      • 6.3.2. Market size and forecast, by Drugs Type

      • 6.3.3. Market size and forecast, by Application

      • 6.3.4. Market size and forecast, by country

        • 6.3.4.1. Germany
          • 6.3.4.1.1. Key market trends, growth factors and opportunities
          • 6.3.4.1.2. Market size and forecast, by Drugs Type
          • 6.3.4.1.3. Market size and forecast, by Application
        • 6.3.4.2. UK
          • 6.3.4.2.1. Key market trends, growth factors and opportunities
          • 6.3.4.2.2. Market size and forecast, by Drugs Type
          • 6.3.4.2.3. Market size and forecast, by Application
        • 6.3.4.3. France
          • 6.3.4.3.1. Key market trends, growth factors and opportunities
          • 6.3.4.3.2. Market size and forecast, by Drugs Type
          • 6.3.4.3.3. Market size and forecast, by Application
        • 6.3.4.4. Spain
          • 6.3.4.4.1. Key market trends, growth factors and opportunities
          • 6.3.4.4.2. Market size and forecast, by Drugs Type
          • 6.3.4.4.3. Market size and forecast, by Application
        • 6.3.4.5. Italy
          • 6.3.4.5.1. Key market trends, growth factors and opportunities
          • 6.3.4.5.2. Market size and forecast, by Drugs Type
          • 6.3.4.5.3. Market size and forecast, by Application
        • 6.3.4.6. Rest of Europe
          • 6.3.4.6.1. Key market trends, growth factors and opportunities
          • 6.3.4.6.2. Market size and forecast, by Drugs Type
          • 6.3.4.6.3. Market size and forecast, by Application
    • 6.4. Asia-Pacific

      • 6.4.1. Key trends and opportunities

      • 6.4.2. Market size and forecast, by Drugs Type

      • 6.4.3. Market size and forecast, by Application

      • 6.4.4. Market size and forecast, by country

        • 6.4.4.1. China
          • 6.4.4.1.1. Key market trends, growth factors and opportunities
          • 6.4.4.1.2. Market size and forecast, by Drugs Type
          • 6.4.4.1.3. Market size and forecast, by Application
        • 6.4.4.2. Japan
          • 6.4.4.2.1. Key market trends, growth factors and opportunities
          • 6.4.4.2.2. Market size and forecast, by Drugs Type
          • 6.4.4.2.3. Market size and forecast, by Application
        • 6.4.4.3. India
          • 6.4.4.3.1. Key market trends, growth factors and opportunities
          • 6.4.4.3.2. Market size and forecast, by Drugs Type
          • 6.4.4.3.3. Market size and forecast, by Application
        • 6.4.4.4. South Korea
          • 6.4.4.4.1. Key market trends, growth factors and opportunities
          • 6.4.4.4.2. Market size and forecast, by Drugs Type
          • 6.4.4.4.3. Market size and forecast, by Application
        • 6.4.4.5. Australia
          • 6.4.4.5.1. Key market trends, growth factors and opportunities
          • 6.4.4.5.2. Market size and forecast, by Drugs Type
          • 6.4.4.5.3. Market size and forecast, by Application
        • 6.4.4.6. Rest of Asia-Pacific
          • 6.4.4.6.1. Key market trends, growth factors and opportunities
          • 6.4.4.6.2. Market size and forecast, by Drugs Type
          • 6.4.4.6.3. Market size and forecast, by Application
    • 6.5. LAMEA

      • 6.5.1. Key trends and opportunities

      • 6.5.2. Market size and forecast, by Drugs Type

      • 6.5.3. Market size and forecast, by Application

      • 6.5.4. Market size and forecast, by country

        • 6.5.4.1. Brazil
          • 6.5.4.1.1. Key market trends, growth factors and opportunities
          • 6.5.4.1.2. Market size and forecast, by Drugs Type
          • 6.5.4.1.3. Market size and forecast, by Application
        • 6.5.4.2. United Arab Emirates
          • 6.5.4.2.1. Key market trends, growth factors and opportunities
          • 6.5.4.2.2. Market size and forecast, by Drugs Type
          • 6.5.4.2.3. Market size and forecast, by Application
        • 6.5.4.3. Saudi Arabia
          • 6.5.4.3.1. Key market trends, growth factors and opportunities
          • 6.5.4.3.2. Market size and forecast, by Drugs Type
          • 6.5.4.3.3. Market size and forecast, by Application
        • 6.5.4.4. South Africa
          • 6.5.4.4.1. Key market trends, growth factors and opportunities
          • 6.5.4.4.2. Market size and forecast, by Drugs Type
          • 6.5.4.4.3. Market size and forecast, by Application
        • 6.5.4.5. Rest of LAMEA
          • 6.5.4.5.1. Key market trends, growth factors and opportunities
          • 6.5.4.5.2. Market size and forecast, by Drugs Type
          • 6.5.4.5.3. Market size and forecast, by Application
  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top winning strategies

    • 7.3. Product Mapping of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top player positioning, 2021

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Fresenius Kabi AG

      • 8.1.1. Company overview

      • 8.1.2. Key Executives

      • 8.1.3. Company snapshot

    • 8.2. Novartis AG

      • 8.2.1. Company overview

      • 8.2.2. Key Executives

      • 8.2.3. Company snapshot

    • 8.3. Aspen Holdings

      • 8.3.1. Company overview

      • 8.3.2. Key Executives

      • 8.3.3. Company snapshot

    • 8.4. Sagent Pharmaceuticals

      • 8.4.1. Company overview

      • 8.4.2. Key Executives

      • 8.4.3. Company snapshot

    • 8.5. Pacira Pharmaceuticals, Inc.

      • 8.5.1. Company overview

      • 8.5.2. Key Executives

      • 8.5.3. Company snapshot

    • 8.6. Mylan N.V.

      • 8.6.1. Company overview

      • 8.6.2. Key Executives

      • 8.6.3. Company snapshot

    • 8.7. Teva Pharmaceutical Industries Ltd.

      • 8.7.1. Company overview

      • 8.7.2. Key Executives

      • 8.7.3. Company snapshot

    • 8.8. Pfizer Inc.

      • 8.8.1. Company overview

      • 8.8.2. Key Executives

      • 8.8.3. Company snapshot

    • 8.9. Septodont Healthcare India Pvt. Ltd.

      • 8.9.1. Company overview

      • 8.9.2. Key Executives

      • 8.9.3. Company snapshot

    • 8.10. Baxter International Inc.

      • 8.10.1. Company overview

      • 8.10.2. Key Executives

      • 8.10.3. Company snapshot

  • LIST OF TABLES

  • TABLE 01. GLOBAL LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 02. LOCAL ANESTHESIA DRUGS MARKET FOR BUPIVACAINE, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 03. LOCAL ANESTHESIA DRUGS MARKET FOR ROPIVACAINE, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 04. LOCAL ANESTHESIA DRUGS MARKET FOR LIDOCAINE, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 05. LOCAL ANESTHESIA DRUGS MARKET FOR CHLOROPROCAINE, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 06. LOCAL ANESTHESIA DRUGS MARKET FOR PRILOCAINE, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 07. LOCAL ANESTHESIA DRUGS MARKET FOR BENZOCAINE, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 08. LOCAL ANESTHESIA DRUGS MARKET FOR OTHER LOCAL ANESTHETICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 09. GLOBAL LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 10. LOCAL ANESTHESIA DRUGS MARKET FOR INJECTABLE, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 11. LOCAL ANESTHESIA DRUGS MARKET FOR SURFACE ANESTHETIC, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 12. LOCAL ANESTHESIA DRUGS MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 13. NORTH AMERICA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 14. NORTH AMERICA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 15. NORTH AMERICA LOCAL ANESTHESIA DRUGS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 16. U.S. LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 17. U.S. LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 18. CANADA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 19. CANADA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 20. MEXICO LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 21. MEXICO LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 22. EUROPE LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 23. EUROPE LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 24. EUROPE LOCAL ANESTHESIA DRUGS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 25. GERMANY LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 26. GERMANY LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 27. UK LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 28. UK LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 29. FRANCE LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 30. FRANCE LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 31. SPAIN LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 32. SPAIN LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 33. ITALY LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 34. ITALY LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 35. REST OF EUROPE LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 36. REST OF EUROPE LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 37. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 38. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 39. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 40. CHINA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 41. CHINA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 42. JAPAN LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 43. JAPAN LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 44. INDIA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 45. INDIA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 46. SOUTH KOREA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 47. SOUTH KOREA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 48. AUSTRALIA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 49. AUSTRALIA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 50. REST OF ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 51. REST OF ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 52. LAMEA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 53. LAMEA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 54. LAMEA LOCAL ANESTHESIA DRUGS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 55. BRAZIL LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 56. BRAZIL LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 57. UNITED ARAB EMIRATES LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 58. UNITED ARAB EMIRATES LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 59. SAUDI ARABIA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 60. SAUDI ARABIA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 61. SOUTH AFRICA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 62. SOUTH AFRICA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 63. REST OF LAMEA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 64. REST OF LAMEA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 65. FRESENIUS KABI AG: KEY EXECUTIVES
    TABLE 66. FRESENIUS KABI AG: COMPANY SNAPSHOT
    TABLE 67. NOVARTIS AG: KEY EXECUTIVES
    TABLE 68. NOVARTIS AG: COMPANY SNAPSHOT
    TABLE 69. ASPEN HOLDINGS: KEY EXECUTIVES
    TABLE 70. ASPEN HOLDINGS: COMPANY SNAPSHOT
    TABLE 71. SAGENT PHARMACEUTICALS: KEY EXECUTIVES
    TABLE 72. SAGENT PHARMACEUTICALS: COMPANY SNAPSHOT
    TABLE 73. PACIRA PHARMACEUTICALS, INC.: KEY EXECUTIVES
    TABLE 74. PACIRA PHARMACEUTICALS, INC.: COMPANY SNAPSHOT
    TABLE 75. MYLAN N.V.: KEY EXECUTIVES
    TABLE 76. MYLAN N.V.: COMPANY SNAPSHOT
    TABLE 77. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY EXECUTIVES
    TABLE 78. TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT
    TABLE 79. PFIZER INC.: KEY EXECUTIVES
    TABLE 80. PFIZER INC.: COMPANY SNAPSHOT
    TABLE 81. SEPTODONT HEALTHCARE INDIA PVT. LTD.: KEY EXECUTIVES
    TABLE 82. SEPTODONT HEALTHCARE INDIA PVT. LTD.: COMPANY SNAPSHOT
    TABLE 83. BAXTER INTERNATIONAL INC.: KEY EXECUTIVES
    TABLE 84. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
  • LIST OF FIGURES

  • FIGURE 01. LOCAL ANESTHESIA DRUGS MARKET, 2021-2031
    FIGURE 02. SEGMENTATION OF LOCAL ANESTHESIA DRUGS MARKET, 2021-2031
    FIGURE 03. TOP INVESTMENT POCKETS IN LOCAL ANESTHESIA DRUGS MARKET (2022-2031)
    FIGURE 04. PORTER FIVE-1
    FIGURE 05. PORTER FIVE-2
    FIGURE 06. PORTER FIVE-3
    FIGURE 07. PORTER FIVE-4
    FIGURE 08. PORTER FIVE-5
    FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALLOCAL ANESTHESIA DRUGS MARKET
    FIGURE 10. IMPACT OF KEY REGULATION: LOCAL ANESTHESIA DRUGS MARKET
    FIGURE 11. MARKET SHARE ANALYSIS: LOCAL ANESTHESIA DRUGS MARKET
    FIGURE 12. PATENT ANALYSIS BY COMPANY
    FIGURE 13. PATENT ANALYSIS BY COUNTRY
    FIGURE 14. REGULATORY GUIDELINES: LOCAL ANESTHESIA DRUGS MARKET
    FIGURE 15. VALUE CHAIN ANALYSIS: LOCAL ANESTHESIA DRUGS MARKET
    FIGURE 16. LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021(%)
    FIGURE 17. COMPARATIVE SHARE ANALYSIS OF LOCAL ANESTHESIA DRUGS MARKET FOR BUPIVACAINE, BY COUNTRY 2021-2031(%)
    FIGURE 18. COMPARATIVE SHARE ANALYSIS OF LOCAL ANESTHESIA DRUGS MARKET FOR ROPIVACAINE, BY COUNTRY 2021-2031(%)
    FIGURE 19. COMPARATIVE SHARE ANALYSIS OF LOCAL ANESTHESIA DRUGS MARKET FOR LIDOCAINE, BY COUNTRY 2021-2031(%)
    FIGURE 20. COMPARATIVE SHARE ANALYSIS OF LOCAL ANESTHESIA DRUGS MARKET FOR CHLOROPROCAINE, BY COUNTRY 2021-2031(%)
    FIGURE 21. COMPARATIVE SHARE ANALYSIS OF LOCAL ANESTHESIA DRUGS MARKET FOR PRILOCAINE, BY COUNTRY 2021-2031(%)
    FIGURE 22. COMPARATIVE SHARE ANALYSIS OF LOCAL ANESTHESIA DRUGS MARKET FOR BENZOCAINE, BY COUNTRY 2021-2031(%)
    FIGURE 23. COMPARATIVE SHARE ANALYSIS OF LOCAL ANESTHESIA DRUGS MARKET FOR OTHER LOCAL ANESTHETICS, BY COUNTRY 2021-2031(%)
    FIGURE 24. LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021(%)
    FIGURE 25. COMPARATIVE SHARE ANALYSIS OF LOCAL ANESTHESIA DRUGS MARKET FOR INJECTABLE, BY COUNTRY 2021-2031(%)
    FIGURE 26. COMPARATIVE SHARE ANALYSIS OF LOCAL ANESTHESIA DRUGS MARKET FOR SURFACE ANESTHETIC, BY COUNTRY 2021-2031(%)
    FIGURE 27. LOCAL ANESTHESIA DRUGS MARKET BY REGION, 2021
    FIGURE 28. U.S. LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
    FIGURE 29. CANADA LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
    FIGURE 30. MEXICO LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
    FIGURE 31. GERMANY LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
    FIGURE 32. UK LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
    FIGURE 33. FRANCE LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
    FIGURE 34. SPAIN LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
    FIGURE 35. ITALY LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
    FIGURE 36. REST OF EUROPE LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
    FIGURE 37. CHINA LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
    FIGURE 38. JAPAN LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
    FIGURE 39. INDIA LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
    FIGURE 40. SOUTH KOREA LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
    FIGURE 41. AUSTRALIA LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
    FIGURE 42. REST OF ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
    FIGURE 43. BRAZIL LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
    FIGURE 44. UNITED ARAB EMIRATES LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
    FIGURE 45. SAUDI ARABIA LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
    FIGURE 46. SOUTH AFRICA LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
    FIGURE 47. REST OF LAMEA LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
    FIGURE 48. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 49. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 50. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 51. PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 52. COMPETITIVE DASHBOARD
    FIGURE 53. COMPETITIVE HEATMAP: LOCAL ANESTHESIA DRUGS MARKET
    FIGURE 54. TOP PLAYER POSITIONING, 2021

Purchase Full Report of
Local Anesthesia Drugs Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue